·
3 MIN READ

Prior authorization of nonopioid pain care prolongs patient suffering

A 10-day trial yields instant pain relief for a patient, but it takes several months to obtain an insurer’s OK for the treatment.

Prior Authorization
·
3 MIN READ

Opioid epidemic: Huge funding boost needed to close treatment gap

Administrative and insurance barriers continue to block access to treatment, AMA President-elect Susan R. Bailey, MD, tells Congress.

Overdose Epidemic
·
4 MIN READ

June 14, 2019: State Advocacy Update

Physicians take steps against opioid epidemic and Vermont removes prior authorization requirements for MAT in the latest AMA state advocacy news.

Advocacy Update
Delegates at the AMA Annual Meeting
·
3 MIN READ

Get rid of market barriers to appropriate pain management

Health insurers, pharmacy benefit management companies and others are making it harder for physicians to provide appropriate care to patients living with pain.

Overdose Epidemic
·
3 MIN READ

Physicians take steps against opioid epidemic, mortality rises

AMA opioids report highlights limited effects of mandates to stem an epidemic underscoring the need for focus on removing barriers to evidence-based treatment.

Press Releases
·
4 MIN READ

Doctors make progress on opioids, call on policymakers to do more 

Opioid prescriptions fell by 33% over five years, says 2019 AMA Opioid Task Force report. Next step: Eliminate barriers to evidence-based treatment. 

Overdose Epidemic
·
3 MIN READ

AMA Opioid Task Force recommendations offer roadmap to policymakers

The AMA Opioid Task Force recommendations call on policymakers to eliminate barriers to treatment and to take additional steps to end the opioid epidemic.

Press Releases
·
5 MIN READ

AMA, MSMA, Manatt: Study on MS reversing opioid epidemic

A new report today by the AMA, Mississippi State Medical Assn (MSMA), and Manatt Health shows Mississippi is adopting strategies to combat the opioid epidemic.

Press Releases
·
5 MIN READ

May 3, 2019: National Advocacy Update

Support for GME, misapplication of opioid prescribing guidelines and more in the latest AMA national health care advocacy news.

Advocacy Update